验证数据展示
经过测试的应用
Positive FC detected in | Con-A treated human PBMCs |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
PE-98112 targets TNFRSF9/CD137 in FC applications and shows reactivity with human samples.
经测试应用 | FC Application Description |
经测试反应性 | human |
免疫原 | Recombinant Protein 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Recombinant |
产品类型 | Antibody |
全称 | tumor necrosis factor receptor superfamily, member 9 |
别名 | TNFRSF9, ILA, CD137, 4-1BB ligand receptor, 4 1BB ligand receptor |
计算分子量 | 28 kDa |
GenBank蛋白编号 | BC006196 |
基因名称 | TNFRSF9/CD137 |
Gene ID (NCBI) | 3604 |
偶联类型 | PE Fluorescent Dye |
最大激发/发射波长 | 496 nm, 565 nm / 578 nm |
形式 | Liquid |
纯化方式 | Protein A purification |
UNIPROT ID | Q07011 |
储存缓冲液 | PBS with 0.09% sodium azide and 0.5% BSA , pH 7.3 |
储存条件 | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
背景介绍
CD137, also known as TNFRSF9 or 4-1BB, is an inducible T cell surface receptor that belongs to the tumor necrosis factor receptor superfamily. CD137 is a transmembrane protein expressed on the surface of activated T-cells. In addition, activation-dependent expression of CD137 has also been found in B lymphocytes, monocytes, and diverse nonlymphoid cell types. CD137 provides a co-stimulatory signal that enhances the survival, and differentiation of cells, and has a crucial role in the development of CD8 cytotoxic T cells and anti-tumor immunity. (PMID: 9826581; 23696891)
实验方案
Product Specific Protocols | |
---|---|
FC protocol for PE TNFRSF9/CD137 antibody PE-98112 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |